278 related articles for article (PubMed ID: 21567170)
1. Improvement of survival and prospect of cure in patients with metastatic breast cancer.
Cheng YC; Ueno NT
Breast Cancer; 2012 Jul; 19(3):191-9. PubMed ID: 21567170
[TBL] [Abstract][Full Text] [Related]
2. [Multimodality treatment concepts for metastatic breast cancer].
Heinemann V; Kahlert S; Stemmler HJ
Internist (Berl); 2010 Nov; 51(11):1358-65. PubMed ID: 21107788
[TBL] [Abstract][Full Text] [Related]
3. Expression of Yes-associated protein (YAP) in metastatic breast cancer.
Kim HM; Jung WH; Koo JS
Int J Clin Exp Pathol; 2015; 8(9):11248-57. PubMed ID: 26617849
[TBL] [Abstract][Full Text] [Related]
4. [Possibilities of surgical treatment in disseminated breast cancer].
Bozhok AA; Semiglazov VF; Semiglazov VV; Topuzov EE; Klimov NA
Vopr Onkol; 2011; 57(4):427-33. PubMed ID: 22191229
[No Abstract] [Full Text] [Related]
5. Primary and secondary distant metastatic breast cancer: two sides of the same coin.
Güth U; Magaton I; Huang DJ; Fisher R; Schötzau A; Vetter M
Breast; 2014 Feb; 23(1):26-32. PubMed ID: 24215983
[TBL] [Abstract][Full Text] [Related]
6. Two cases with a long-term survival following multidisciplinary treatment for recurrent breast cancer after surgery.
Uramoto H; Hanagiri T
Anticancer Res; 2011 Jan; 31(1):277-9. PubMed ID: 21273610
[TBL] [Abstract][Full Text] [Related]
7. International guidelines for management of metastatic breast cancer: can metastatic breast cancer be cured?
Pagani O; Senkus E; Wood W; Colleoni M; Cufer T; Kyriakides S; Costa A; Winer EP; Cardoso F;
J Natl Cancer Inst; 2010 Apr; 102(7):456-63. PubMed ID: 20220104
[TBL] [Abstract][Full Text] [Related]
8. New insights into patterns of first metastatic sites influencing survival of patients with hormone receptor-positive, HER2-negative breast cancer: a multicenter study of 271 patients.
Yamamura J; Kamigaki S; Fujita J; Osato H; Manabe H; Tanaka Y; Shinzaki W; Hashimoto Y; Komoike Y
BMC Cancer; 2021 Apr; 21(1):476. PubMed ID: 33926418
[TBL] [Abstract][Full Text] [Related]
9. Treatment Strategies for Oligometastatic Breast Cancer.
Nesbit EG; Donnelly ED; Strauss JB
Curr Treat Options Oncol; 2021 Aug; 22(10):94. PubMed ID: 34426881
[TBL] [Abstract][Full Text] [Related]
10. Prognosis for patients with metastatic breast cancer who achieve a no-evidence-of-disease status after systemic or local therapy.
Bishop AJ; Ensor J; Moulder SL; Shaitelman SF; Edson MA; Whitman GJ; Bishnoi S; Hoffman KE; Stauder MC; Valero V; Buchholz TA; Ueno NT; Babiera G; Woodward WA
Cancer; 2015 Dec; 121(24):4324-32. PubMed ID: 26348887
[TBL] [Abstract][Full Text] [Related]
11. B
Stueber TN; Wischnewsky M; Leinert E; Diessner J; Bartmann C; Stein RG; Woeckel A
Clin Breast Cancer; 2019 Oct; 19(5):333-339. PubMed ID: 31281053
[TBL] [Abstract][Full Text] [Related]
12. Subdivision of M1 Stage for De Novo Metastatic Breast Cancer to Better Predict Prognosis and Response to Primary Tumor Surgery.
Lin C; Wu J; Ding S; Goh C; Andriani L; Lu S; Shen K; Zhu L
J Natl Compr Canc Netw; 2019 Dec; 17(12):1521-1528. PubMed ID: 31805535
[TBL] [Abstract][Full Text] [Related]
13. Survival differences in patients with metastatic colorectal cancer and with single site metastatic disease at initial presentation: results from South Australian clinical registry for advanced colorectal cancer.
Khattak MA; Martin HL; Beeke C; Price T; Carruthers S; Kim S; Padbury R; Karapetis CS
Clin Colorectal Cancer; 2012 Dec; 11(4):247-54. PubMed ID: 22763194
[TBL] [Abstract][Full Text] [Related]
14. A systemic late recurrence after the first operation in a patient diagnosed with early-stage breast cancer: the latest recurrence in the literature.
Durdu Keskin O; Kertmen N; Karakas Y; Babacan T; Arik Z; Altundag K; Gullu I
J BUON; 2015; 20(1):348. PubMed ID: 25778338
[No Abstract] [Full Text] [Related]
15. De novo metastasis in breast cancer: occurrence and overall survival stratified by molecular subtype.
Press DJ; Miller ME; Liederbach E; Yao K; Huo D
Clin Exp Metastasis; 2017 Dec; 34(8):457-465. PubMed ID: 29288366
[TBL] [Abstract][Full Text] [Related]
16. Different Breast Cancer Subtypes Show Different Metastatic Patterns: A Study from A Large Public Database.
Guo Y; Arciero CA; Jiang R; Behera M; Peng L; Li X
Asian Pac J Cancer Prev; 2020 Dec; 21(12):3587-3593. PubMed ID: 33369456
[TBL] [Abstract][Full Text] [Related]
17. Distant metastatic breast cancer as an incurable disease: a tenet with a need for revision.
Güth U; Huang DJ; Dirnhofer S; Rochlitz C; Wight E
Cancer J; 2009; 15(1):81-6. PubMed ID: 19197181
[TBL] [Abstract][Full Text] [Related]
18. Sites of distant metastases and overall survival in ovarian cancer: A study of 1481 patients.
Deng K; Yang C; Tan Q; Song W; Lu M; Zhao W; Lou G; Li Z; Li K; Hou Y
Gynecol Oncol; 2018 Sep; 150(3):460-465. PubMed ID: 30001833
[TBL] [Abstract][Full Text] [Related]
19. Effect of hormone therapy on long-term outcomes of patients with human epidermal growth factor receptor 2- and hormone receptor-positive metastatic breast cancer: real world experience in China.
Du F; Yuan P; Wang JY; Ma F; Fan Y; Luo Y; Xu BH
Asian Pac J Cancer Prev; 2015; 16(3):903-7. PubMed ID: 25735380
[TBL] [Abstract][Full Text] [Related]
20. Prognostic Value of Site-Specific Metastases and Surgery in De Novo Stage IV Triple-Negative Breast Cancer: A Population-Based Analysis.
Gu Y; Wu G; Zou X; Huang P; Yi L
Med Sci Monit; 2020 Feb; 26():e920432. PubMed ID: 32043484
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
